Weekly systemic combination of cisplatin and interferon α2a in diffuse malignant pleural mesothelioma
- 30 November 1998
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 22 (2) , 119-125
- https://doi.org/10.1016/s0169-5002(98)00072-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Current Therapy for MesotheliomaCancer Control, 1997
- Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesotheliomaCancer, 1997
- Effect of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesotheliomas: a nonrandomized phase II studyEuropean Respiratory Journal, 1996
- Chemotherapy in malignant pleural mesothelioma. A review.Journal of Clinical Oncology, 1996
- Continuing increase in mesothelioma mortality in BritainThe Lancet, 1995
- A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.Journal of Clinical Oncology, 1994
- Pleurectomy/Decortication and Adjuvant Therapy for Malignant MesotheliomaChest, 1993
- Malignant pleural mesothelioma in western Glasgow 1980-6.Thorax, 1989
- Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.Thorax, 1984
- Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experienceCancer, 1983